Jody Goldstein

Neurocrine Biosciences (United States) — United States

Neuroscience · Life Sciences

8h-index837citations13works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Neurodegenerative Diseases(11), Neurological disorders and treatments(9), Neurological and metabolic disorders(3), Mitochondrial Function and Pathology(2), Botulinum Toxin and Related Neurological Disorders(2)

Publications12 total

Sustained Chorea Improvements with Long-term, Once-daily Valbenazine in Adults with Huntington’s Disease (S37.009)
Neurology·2025
Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease
CNS Drugs·2025· 2 citedOpen Access
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
CNS Drugs·2022· 28 citedOpen Access
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial
Nature Medicine·2022· 57 citedOpen Access
Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington’s Disease: Results From the ARC-HD Open-label Study
CNS Spectrums·2021· 2 citedOpen Access
Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington’s Disease
CNS Spectrums·2021Open Access
Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington’s Disease (4310)
Neurology·2020· 1 cited
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
JAMA Neurology·2017· 209 cited
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
JAMA·2016· 391 citedOpen Access
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
Publisher·2016· 44 cited
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)
JAMA Neurology·2015· 46 citedOpen Access
Diagnostic and therapeutic approach to pancreatic cancer
Biomedicine & Pharmacotherapy·2000· 29 cited

Frequent Co-authors

Elise Kayson(12), Samuel Frank(10), David Oakes(10), Claudia Testa(9), Christina Vaughan(8), Jacquelyn Whaley(8), David Stamler(7), Blair R. Leavitt(6), Christine J. O’Neill(6), Daniel O. Claassen(6), Joseph Jankovic(5), Christine Hunter(5), Victor Sung(5), Brad A. Racette(5), Stewart A. Factor(5), Ali Samii(5), Sylvain Chouinard(5), Andrew P. Duker(5), Shirley Eberly(5), Mark Forrest Gordon(5)